Q3 marks the low point on the current estimate profile
Ahead of Q3, we estimate sales of SEK 40m (down 40% y/y). We forecast BIP sales of SEK 3.9m in Bactiguard territories, SEK 11m contribution from Vigilenz and no sales contribution from Well Lead, leading to sales of BIP products of SEK 15m. We forecast old licence sales of SEK 21m and no new licence sales. On earnings, we expect lower sales to cause a lower gross margin (79.6% vs. 85.6% in H1), which is set to limit the earnings generation in Q3 (adj. EBITDA SEK 0.7m).
LÄS MER